amylyx glp-1 Pharmaceuticals Announces Acquisition of Phase 3-ready Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation Craving Reduction Comprehensive Metabolic Health Amylyx acquires Eiger's GLP-1 antagonist
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


























